ES8801372A1 - Methods and compositions useful in preventing equine influenza. - Google Patents

Methods and compositions useful in preventing equine influenza.

Info

Publication number
ES8801372A1
ES8801372A1 ES556256A ES556256A ES8801372A1 ES 8801372 A1 ES8801372 A1 ES 8801372A1 ES 556256 A ES556256 A ES 556256A ES 556256 A ES556256 A ES 556256A ES 8801372 A1 ES8801372 A1 ES 8801372A1
Authority
ES
Spain
Prior art keywords
vaccines
equine influenza
methods
eiv
dna sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556256A
Other languages
Spanish (es)
Other versions
ES556256A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotechnology Research Partners Ltd
Original Assignee
Biotechnology Research Partners Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Research Partners Ltd filed Critical Biotechnology Research Partners Ltd
Publication of ES8801372A1 publication Critical patent/ES8801372A1/en
Publication of ES556256A0 publication Critical patent/ES556256A0/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Recombinant vaccines for immunizing horses against equine influenza virus (EIV) are disclosed. The DNA sequences encoding the hemagluttinin (HA) and neuraminidase (NA) glycoproteins from the two strains of EIV currently infective in horses are used to construct vaccinia carried vaccines, to design synthetic peptides for primer and booster administration, and to permit recombinant synthesis of HA and/or NA protein based vaccines. These DNA sequences also provide probes useful for preparing similar vaccines from fresh isolates of new strains generated by genetic drift.
ES556256A 1985-06-20 1986-06-19 Methods and compositions useful in preventing equine influenza. Expired ES8801372A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/747,020 US4631191A (en) 1985-06-20 1985-06-20 Methods and compositions useful in preventing equine influenza

Publications (2)

Publication Number Publication Date
ES8801372A1 true ES8801372A1 (en) 1987-12-16
ES556256A0 ES556256A0 (en) 1987-12-16

Family

ID=25003339

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556256A Expired ES8801372A1 (en) 1985-06-20 1986-06-19 Methods and compositions useful in preventing equine influenza.

Country Status (5)

Country Link
US (1) US4631191A (en)
EP (1) EP0229826A4 (en)
AU (1) AU6125386A (en)
ES (1) ES8801372A1 (en)
WO (1) WO1986007593A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866136A (en) * 1986-08-01 1999-02-02 Commonwealth Scientific And Industrial Organisation Recombinant vaccine
US5348741A (en) * 1987-02-03 1994-09-20 The United States Of America As Represented By The Department Of Health And Human Services Vector for recombinant poxvirus expressing rabies virus glycoprotein
WO1990002762A1 (en) 1988-09-02 1990-03-22 The Rockefeller University Macrophage-derived inflammatory mediator (mip-2)
ES2082850T3 (en) * 1989-02-24 1996-04-01 Univ California GENETICALLY PREPARED IMMUNOGLOBULINS.
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
US5620896A (en) * 1992-03-23 1997-04-15 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US6165993A (en) * 1992-03-23 2000-12-26 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US6485729B1 (en) * 1993-09-13 2002-11-26 Protein Sciences Corporation Neuraminidase-supplemented compositions
FR2751226B1 (en) * 1996-07-19 1998-11-27 Rhone Merieux POLYNUCLEOTIDE VACCINE FORMULA AGAINST HORSE PATHOLOGIES
US6482414B1 (en) 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6579528B1 (en) 1998-08-13 2003-06-17 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6177082B1 (en) 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6249570B1 (en) * 1999-06-08 2001-06-19 David A. Glowny System and method for recording and storing telephone call information
CA2403979A1 (en) * 2000-04-03 2001-10-11 The University Of Pittsburgh Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
WO2005014778A2 (en) * 2003-05-15 2005-02-17 The Board Of Regents For Oklahoma State University Dna vaccine expressing ha1 of equine-2 influenza virus
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
KR101123657B1 (en) * 2009-11-23 2012-03-20 최장호 Sporting goods for strengthening muscle
CN102180927A (en) * 2011-03-25 2011-09-14 中国人民解放军军事医学科学院微生物流行病研究所 Method for obtaining influenza virus nucleic acid in influenza sample and special primer thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357421A (en) * 1979-04-02 1982-11-02 G. D. Searle & Co. Synthetic gene coding for influenza hemagglutinin
US4455142A (en) * 1980-07-07 1984-06-19 Alza Corporation Method of coadministering an antigen and an immunopotentiator
US4548814A (en) * 1980-12-18 1985-10-22 The Board Of Trustees Of The University Of Illinois Composition of matter and process
IL61904A (en) * 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
DE3381376D1 (en) * 1982-04-16 1990-05-03 Cornell Res Foundation Inc TEMPERATURE-SENSITIVE REASSORTING VIRUSES AND VACCINE AGAINST HORSE INFLUENCE.
SE8205892D0 (en) * 1982-10-18 1982-10-18 Bror Morein IMMUNOGENT MEMBRANE PROTEIN COMPLEX, SET FOR PREPARATION AND USE THEREOF
GB8300467D0 (en) * 1983-01-08 1983-02-09 Wellcome Found Equine influenza

Also Published As

Publication number Publication date
EP0229826A1 (en) 1987-07-29
US4631191A (en) 1986-12-23
ES556256A0 (en) 1987-12-16
WO1986007593A1 (en) 1986-12-31
AU6125386A (en) 1987-01-13
EP0229826A4 (en) 1989-03-29

Similar Documents

Publication Publication Date Title
ES8801372A1 (en) Methods and compositions useful in preventing equine influenza.
Wunner et al. Antigenic variants of CVS rabies virus with altered glycosylation sites
DE69333397D1 (en) RETRO, INVERSO, AND RETRO INVERSO SYNTHETIC PEPTIDE ANALOGS
KR900700508A (en) Chimeric glycoprotein containing glycoprotein immune fragments against human respiratory syncytial virus
SE9004010D0 (en) VIRAL MEDICINE
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
EP0414689A4 (en) Pox virus vectors
NO852567L (en) THYMOPENTIN ANALOGS AND PROCEDURES FOR THEIR PREPARATION.
ES8500997A1 (en) Small peptides with the specificity of foot and mouth disease viral antigens.
HUP0002472A2 (en) Isolated dendritic cell membrane protein genes
ZA936970B (en) Anti-feline immunodeficiency virus (FIV) vaccines
KR890700030A (en) Vaccines and diagnostic methods for influenza (Haemophilus influenzae)
DK11187D0 (en) DNA SEQUENCES CODING FOR HUSI TYPE PROTEINS IN THE BIOLOGICAL ACTIVITY OF INHIBITORS, BIOTECHNICAL PROCEDURES FOR PREPARING THE PROTEINS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
ATE101200T1 (en) VACCINES AGAINST HUMAN RESPIRATORY VIRUSES.
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
HUP9901005A2 (en) Glycoprotein b of the rfhv/kshv subfamily of herpes viruses
Stampfer et al. Identification of the vesicular stomatitis virus large protein as a unique viral protein
NO984491L (en) SCF analog preparations and methods for their preparation
Kos et al. Induction of primary anti‐viral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin‐7
DE68923286D1 (en) Vaccines and test kits for Haemophilus Influenza.
NZ507983A (en) A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
ES8800358A1 (en) Vaccinal polypeptides.
Roy Phosphoproteins of spring viremia of carp virus
Irving et al. Shedding of vesicular stomatitis virus soluble glycoprotein by removal of carboxy-terminal peptide
Kotwal et al. Viral membrane glycoproteins: Comparison of the amino acid terminal amino acid sequences of the precursor and mature glycoproteins of three serotypes of vesicular stomatitis virus